Insights on Life Sciences
Article
The emerging epicenter: Asia’s role in biopharma’s future
-
Asia is now the epicenter of global biopharmaceutical progress—outpacing the United States and Europe in pipeline growth, patents, and next-gen therapies.
Article
AI drug discovery: Focusing on what matters most
-
AI is accelerating drug discovery, but investment has concentrated in molecule design—the stage with the best data and...
Podcast
Novartis’s Christian Diehl on scaling AI beyond the demo
-
Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off...
Article
Backbones and networks: A blueprint for the biopharma plant of the future
-
As their portfolios become more complex and productivity gains slow, biopharma manufacturers are investing heavily to keep pace...
Podcast
AstraZeneca’s Bob Li on the MARS mission to eliminate cancer
-
Bob Li, AstraZeneca’s Senior Vice President, Global Head of Medical Affairs, Oncology, on why only 7 percent of cancer...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.